AzTrials
AzTrials

Acute Respiratory FailureWEAN-EITNCT05726513

Evaluation of Regional Ventilation Distribution Using Electrical Impedance Tomography During Weaning From Mechanical Ventilation

A study testing Weaning trial - Low support, high Positive end-expiratory pressure, Weaning trial - Low support, zero positive end-expiratory pressure and Weaning trial - Zero support, zero positive end-expiratory pressure in people with Acute Respiratory Failure and Mechanical Ventilation Complication, run by Università degli Studi di Ferrara at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this physiological cross-over clinical trial is to evaluate the effect of different clinically used weaning trials on regional mechanical ventilation in a population of patients undergoing weaning from mechanical ventilation for acute respiratory failure. Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Weaning trial - Low support, high Positive end-expiratory pressure, Weaning trial - Low support, zero positive end-expiratory pressure and Weaning trial - Zero support, zero positive end-expiratory pressure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
15 Feb 2023to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 18 and < 70 years
  • Ready to be weaned from mechanical ventilation according to clinical criteria

Who cannot join

  • Age < 18 years or > 70 years
  • Presence of chest drains
  • Presence of pacemaker/impantable cardiac device;
  • diagnosis of Pneumothorax, or pneumomediastinum
  • Diagnois of neuromuscular diseases
  • Use of neuromuscular blockers in the 48 hours before screening;
  • Body mass index > 35 kg/m2
  • Refusal to participate of the patient/next of kin

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Azienda Ospedaliero Universitaria Sant'Anna

    Ferrara, 44121

    Savino Spadaro, MD, +390532239780, savinospadaro@gmail.com

    Gaetano Scaramuzzo, MD

    Recruiting

Other trials in Italy

About this study

The goal of this physiological cross-over clinical trial is to evaluate the effect of different clinically used weaning trials on regional mechanical ventilation in a population of patients undergoing weaning from mechanical ventilation for acute respiratory failure.

The main question[s] it aims to answer are:

Read more
  • to evaluate which weaning trial is associated to a better regional ventilation distribution
  • to evaluate which weaning trial can be comparable to ventilation distribution after extubation

Participants will undergo 3 clinically used weaning trials in a random order (cross-over trial). Researchers will compare the different steps to see if regional ventilation distribution is different among the different trial .

Being tested
Weaning trial - Low support, high Positive end-expiratory pressure, Weaning trial - Low support, zero positive end-expiratory pressure, Weaning trial - Zero support, zero positive end-expiratory pressure
Keywords
Electrical Impedance tomography, Weaning trial, Acute respiratory failure, Lung monitoring
Medical subject headings
Ventilator-Induced Lung Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Weaning trial - Low support, high Positive end-expiratory pressureDiagnostic test

    The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with low pressure support ventilation and a positive end expiratory pressure of 5 cmH2O

  • Weaning trial - Low support, zero positive end-expiratory pressureDiagnostic test

    The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with low pressure support ventilation and a positive end expiratory pressure of 0 cmH2O

  • Weaning trial - Zero support, zero positive end-expiratory pressureDiagnostic test

    The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with 0 pressure support ventilation and a positive end expiratory pressure of 0 cmH2O

Study groups in NCT05726513
Study groupRoleWhat they receive
Low support, high Positive end-expiratory pressureOtherLow support, high Positive end-expiratory pressure
Receives: Diagnostic Test: Weaning trial - Low support, high Positive end-expiratory pressure
Low support, zero positive end-expiratory pressureOtherLow support, zero positive end-expiratory pressure
Receives: Diagnostic Test: Weaning trial - Low support, zero positive end-expiratory pressure
Zero support, zero positive end-expiratory pressureOtherZero support, zero positive end-expiratory pressure
Receives: Diagnostic Test: Weaning trial - Zero support, zero positive end-expiratory pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Regional Ventilation distribution using Electrical Impedance Tomography

    The researchers will evaluate differences in ventilation distribution pattern among the different weaning trials using Electrical Impedance Tomography and focusing on:

    • Regional ventilation distribution
    • Regional inhomogeneity
    • Regional compliance distribution
    • Center of Ventilation
    • Silent Spaces

    Measured: 2 hours

Secondary outcomes (1)
  1. Differences in Regional Ventilation distribution using Electrical Impedance Tomography between weaning trials and post-extubation phase

    The researchers will evaluate differences in ventilation distribution pattern among the different weaning trials and the post-extubation phase using Electrical Impedance Tomography and focusing on:

    • Regional ventilation distribution
    • Regional inhomogeneity
    • Regional compliance distribution
    • Center of Ventilation
    • Silent Spaces

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2023
  2. Study start15 Feb 2023 (estimated)
  3. Primary completion30 May 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05726513
Sponsor's protocol ID
WEAN-EIT
Acronym
WEAN-EIT
Status last verified
Feb 2023
First submitted
13 Jan 2023
Last updated
14 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Weaning trial - Low support, high Positive end-expiratory pressure, Weaning trial - Low support, zero positive end-expiratory pressure and Weaning trial - Zero support, zero positive end-expiratory pressure in people with Acute Respiratory Failure and Mechanical Ventilation Complication, run by Università degli Studi di Ferrara at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Regional Ventilation distribution using Electrical Impedance Tomography (time frame: 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in